| Derron Wilson, MD | |
|
13345 Illinois St, Carmel, IN 46032-3318 | |
| (317) 396-1300 | |
| (317) 870-2728 |
| Full Name | Derron Wilson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 28 Years |
| Location | 13345 Illinois St, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780669267 | NPI | - | NPPES |
| 200313770B | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 01047150A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indianapolis Neurosurgical Group Pc | 0941191282 | 46 |
News Archive
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
The Prix Galien USA committee celebrated members of the science and biotechnology industries last night for the development and discovery of drugs and technologies that improve the human condition.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
CTI BioPharma Corp. today announced that it has amended its existing loan agreement with Hercules Technology Growth Capital, Inc. (Hercules). Pursuant to the amendment, Hercules agreed to provide term loans in an aggregate principal amount of up to $25.0 million under the facility, inclusive of amounts outstanding immediately prior to closing of the amendment.
Researchers from the University of Melbourne have come up with devices called ventilation hoods that could help decrease the spread of COVID-19 from ICU patients to health workers who treat them, and to other patients.
› Verified 7 days ago
| Entity Name | Indianapolis Neurosurgical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275580318 PECOS PAC ID: 0941191282 Enrollment ID: O20040324000655 |
News Archive
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
The Prix Galien USA committee celebrated members of the science and biotechnology industries last night for the development and discovery of drugs and technologies that improve the human condition.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
CTI BioPharma Corp. today announced that it has amended its existing loan agreement with Hercules Technology Growth Capital, Inc. (Hercules). Pursuant to the amendment, Hercules agreed to provide term loans in an aggregate principal amount of up to $25.0 million under the facility, inclusive of amounts outstanding immediately prior to closing of the amendment.
Researchers from the University of Melbourne have come up with devices called ventilation hoods that could help decrease the spread of COVID-19 from ICU patients to health workers who treat them, and to other patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derron Wilson, MD 13345 Illinois St, Carmel, IN 46032-3318 Ph: (317) 396-1300 | Derron Wilson, MD 13345 Illinois St, Carmel, IN 46032-3318 Ph: (317) 396-1300 |
News Archive
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
The Prix Galien USA committee celebrated members of the science and biotechnology industries last night for the development and discovery of drugs and technologies that improve the human condition.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
CTI BioPharma Corp. today announced that it has amended its existing loan agreement with Hercules Technology Growth Capital, Inc. (Hercules). Pursuant to the amendment, Hercules agreed to provide term loans in an aggregate principal amount of up to $25.0 million under the facility, inclusive of amounts outstanding immediately prior to closing of the amendment.
Researchers from the University of Melbourne have come up with devices called ventilation hoods that could help decrease the spread of COVID-19 from ICU patients to health workers who treat them, and to other patients.
› Verified 7 days ago
David E Kline, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 151 Pennsylvania Pkwy, Carmel, IN 46280 Phone: 317-577-4200 Fax: 317-577-9503 | |
Peter Cushman Houck, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10580 N Meridian St, Carmel, IN 46290 Phone: 317-583-5000 | |
Lorenzo Thomas Hughes, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 151 Pennsylvania Pkwy, Carmel, IN 46280 Phone: 317-732-0050 Fax: 317-732-0050 | |
Wayne Richard Woodard, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11700 N Meridian St, Carmel, IN 46032 Phone: 317-577-4200 Fax: 317-577-9203 | |
Dr. Stephen H Castleman, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 151 Pennsylvania Pkwy, Carmel, IN 46280 Phone: 317-577-4200 Fax: 317-577-9503 | |
Allison C Malley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 151 Pennsylvania Pkwy, Carmel, IN 46280 Phone: 317-577-4200 Fax: 317-577-9503 | |
Sagar J Patel, CAA Anesthesiology Medicare: Medicare Enrolled Practice Location: 11700 N Meridian St Ste 4110, Carmel, IN 46032 Phone: 317-577-4200 Fax: 317-577-4200 |